Abstract
Cyclodextrins are able to interact in biocatalysis reaction. Their effects as solubilizing agents, inhibitor blocking agents and chiral selectors are well documented and they also interact before the enzyme-catalyzed reaction. Indeed, they have lyo-protectant effect for enzyme in organic medium biocatalysis and they participate in the refolding of inactive enzymes to regain their active form.
Keywords: Cyclodextrin, Biocatalysis, Enzyme, Lyo-protectant, Refolding
Current Organic Chemistry
Title: Enzymatic Catalysis in Presence of Cyclodextrins
Volume: 14 Issue: 13
Author(s): V. Bonnet, C. Gervaise, A. Favrelle, C. Sarazin and F. Djedaini-Pilard
Affiliation:
Keywords: Cyclodextrin, Biocatalysis, Enzyme, Lyo-protectant, Refolding
Abstract: Cyclodextrins are able to interact in biocatalysis reaction. Their effects as solubilizing agents, inhibitor blocking agents and chiral selectors are well documented and they also interact before the enzyme-catalyzed reaction. Indeed, they have lyo-protectant effect for enzyme in organic medium biocatalysis and they participate in the refolding of inactive enzymes to regain their active form.
Export Options
About this article
Cite this article as:
Bonnet V., Gervaise C., Favrelle A., Sarazin C. and Djedaini-Pilard F., Enzymatic Catalysis in Presence of Cyclodextrins, Current Organic Chemistry 2010; 14 (13) . https://dx.doi.org/10.2174/138527210791616849
DOI https://dx.doi.org/10.2174/138527210791616849 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Impact of Combinatorial Methodologies on Medicinal Chemistry
Current Topics in Medicinal Chemistry Roles of p75NTR in Maintaining Brain Hemostasis and the Implications for p75NTR-targeted Therapies
Current Alzheimer Research ‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports
Current Neuropharmacology Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Current Pharmaceutical Design Anionic Linear Globular Dendrimer-G2-Ciprofloxacin Nano-Conjugate: Novel Agent against Wilson Disease Cell Model
Letters in Drug Design & Discovery An Overview of Published Papers and Important Developments in the Past Three Years
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Effects of a Long-Term Treatment with an Antioxidant Pyridoindole on Vascular Responsiveness in Diabetes-Induced Aging Rats
Current Aging Science Genetics of Serotonin Receptors and Depression: State of the Art
Current Drug Targets Graphical Abstracts:
Letters in Drug Design & Discovery Pharmacokinetic Concepts Revisited - Basic and Applied
Current Pharmaceutical Biotechnology The Effect of Spinal Cord Injury on Beta-Amyloid Plaque Pathology in TgCRND8 Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Induced Pluripotent Stem Cells, New Tools for Drug Discovery and New Hope for Stem Cell Therapies
Current Molecular Pharmacology Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach
Current Neuropharmacology Tissue Plasminogen Activator Prevents Restoration of Tight Junction Proteins Through Upregulation of Angiopoietin-2
Current Neurovascular Research Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
CNS & Neurological Disorders - Drug Targets The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders
Current Drug Targets - CNS & Neurological Disorders Looking Towards New Pathogenetic Mechanisms in Parkinson’s Disease: is ANT1 the Potential Candidate?
Current Aging Science How to Review the Medication History to Find the Next Best Drug: The “Pretreatment-Next Treatment Algorithm and Checklist”
Current Psychopharmacology Targeting PPARalpha in Alzheimer's Disease
Current Alzheimer Research